MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
APUS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Apimeds Pharmaceuticals US (APUS) Ownership - Who owns Apimeds Pharmaceuticals US?

Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
100 Matawan Road
Phone
+1 848 201-5010
Employees
7
Web
https://www.apimedsus.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
3.18M
P/E Ratio
N/A
Total Cash
278.37K
Projected Growth
N/A
Total Debt
14.57M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.18
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
APUS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for APUS
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Details
Industry
N/A
Address
100 Matawan Road
Phone
+1 848 201-5010
Employees
7
Web
https://www.apimedsus.com
Who owns Apimeds Pharmaceuticals US? APUS symbol Ownership - Tickeron.com